FDA Approves Zituvimet (sitagliptin and metformin hydrochloride) to Treat Adult Patients With Type 2 Diabetes Mellitus

November 06, 2023, Ahmedabad, India --  Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as " Zydus " ) today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news